Form 4: Fulgent Genetics COO Sells Shares for Tax Obligations

Fulgent Genetics' President and COO, Jian Xie, sold 696 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Jian Xie, President and COO of Fulgent Genetics, Inc. (FLGT), sold 696 shares of common stock.
• The transaction occurred on August 25, 2025, at a weighted-average price of $21.5016 per share.
• The sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 23, 2023.
• Following the transaction, Mr. Xie directly owns 366,448 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.

Sentiment

Score: 5

Explanation: The transaction is a routine sale for tax purposes, indicating a neutral sentiment. It does not reflect a change in the executive's confidence in the company's future performance.

Future Outlook

NA

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• Jian Xie serves on the investment committee of The Hsieh Family Dynasty Trust, which indirectly holds 220,816 shares of Fulgent Genetics common stock. Mr. Xie disclaims beneficial interest except for any pecuniary interest.

Stakeholder Impact

• The sale of 696 shares by an executive for tax purposes is a minor transaction and is unlikely to have a material impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Fulgent Genetics, FLGT, Jian Xie, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Officer Transaction